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Abstract
Mitochondria integrate distinct signals that reflect specific threats to the host, including infection, tissue damage, and
metabolic dysfunction; and play a key role in insulin resistance. We have found that the Pseudomonas aeruginosa quorum
sensing infochemical, 2-amino acetophenone (2-AA), produced during acute and chronic infection in human tissues,
including in the lungs of cystic fibrosis (CF) patients, acts as an interkingdom immunomodulatory signal that facilitates
pathogen persistence, and host tolerance to infection. Transcriptome results have led to the hypothesis that 2-AA causes
further harm to the host by triggering mitochondrial dysfunction in skeletal muscle. As normal skeletal muscle function is
essential to survival, and is compromised in many chronic illnesses, including infections and CF-associated muscle wasting,
we here determine the global effects of 2-AA on skeletal muscle using high-resolution magic-angle-spinning (HRMAS),
proton (
1H) nuclear magnetic resonance (NMR) metabolomics, in vivo
31P NMR, whole-genome expression analysis and
functional studies. Our results show that 2-AA when injected into mice, induced a biological signature of insulin resistance
as determined by
1H NMR analysis-, and dramatically altered insulin signaling, glucose transport, and mitochondrial
function. Genes including Glut4, IRS1, PPAR-c, PGC1 and Sirt1 were downregulated, whereas uncoupling protein UCP3 was
up-regulated, in accordance with mitochondrial dysfunction. Although 2-AA did not alter high-energy phosphates or pH by
in vivo
31P NMR analysis, it significantly reduced the rate of ATP synthesis. This affect was corroborated by results
demonstrating down-regulation of the expression of genes involved in energy production and muscle function, and was
further validated by muscle function studies. Together, these results further demonstrate that 2-AA, acts as a mediator of
interkingdom modulation, and likely effects insulin resistance associated with a molecular signature of mitochondrial
dysfunction in skeletal muscle. Reduced energy production and mitochondrial dysfunctional may further favor infection,
and be an important step in the establishment of chronic and persistent infections.
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Introduction
Pathogens modulate host cell functions to promote their own
survival within the host dynamic environment, and to evade the
host immune system by hijacking functions of cell organelles,
including plasma rafts [1], golgi [2], and mitochondria [3].
Mitochondria act as signaling platforms in diverse biological
processes, including apotosis [3], metabolism, and innate immune
signaling [4]. Bacterial small molecules can alter mitochondrial
function [5], [6], with bacterial effector proteins and toxins
primarily affecting mitochondrial programmed apotosis [3]; and
bacterial membrane constituents, such as lipopolysaccharide (LPS)
and peptidoglycan (PGN) triggering metabolic diseases, including
insulin resistance [7].
Environmental stimuli can alter mitochondrial function via
coordinated changes in gene expression [8]. For instance, specific
members of the peroxisomal proliferator activator receptor
(PPAR)-c and proliferator activator receptor (PPAR)-c coactivator
(PGC1) gene families respond to physiological stimuli to regulate
genes that control mitochondrial biogenesis [9], nuclear and
mitochondrial oxidative metabolism, tricarboxylic acid (TCA)
cycle enzymes, whole body glucose homeostasis, and lipid
oxidation and electron transport complexes [10]. Also, cellular
stress and infection are sensed by the innate immune system by
pattern recognition receptors, which upon activation, initiate
defense and repair pathways [11], [12]. It is possible that, similarly
to viruses, bacteria may activate the inflammasome via altered cell
metabolism and mitochondrial activity [13–16].
Metabolic responses begin promptly upon the initiation of
infection, and progress as a series of coordinated events [17].
Mitochondria may play a key role in the development of insulin
PLOS ONE | www.plosone.org 1 September 2013 | Volume 8 | Issue 9 | e74528resistance [18]. For example, glucose stimulated insulin secretion
from pancreatic b cells requires intact mitochondrial function [19]:
modifications in mitochondrial oxidative activity and mitochon-
drial adenosine triphosphate synthesis is linked to insulin resistance
[19], and these changes involve the up-regulation of mitochondrial
uncoupling proteins (UCPs) [20]; altered mitochondrial fatty acid
oxidation, together with the accumulation of intracellular fatty
acid metabolites (acyl-CoA and diacylglycerol), disrupts insulin
signaling, a phenomenon exacerbated by free fatty acids (FFA)
[21]; and genes involved in mitochondria biogenesis such as the
PPAR-c and PGC-1 (a and b are down-regulated in patients with
insulin resistance [22], [23] and possibly also down-regulated in
insulin resistant cystic fibrosis (CF) patients [24], [25].
CF patients are particularly susceptible to highly problematic
Pseudomonas aeruginosa infections. This pathogen, which causes
chronic infections that are often intractable to traditional antibiotic
therapy [26],[27], employs cell-to-cell communication systems,
termed quorum sensing (QS). QS regulates collective behaviors,
including virulence, that depend on the actions of specific excreted
diffusible small molecular signals, termed infochemicals [28], [29].
QS infochemicals also act as immunomodulatory signals [30],
[31], and respiratory chain inhibitors [6]. The infochemical 2-
amino-acetophenon (2-AA) [32], [33] signals phenotypic changes
in the pathogen [34], and modulates host immune responses [31]
that favor chronic infections, and potentially compromise host
metabolism.
Here we employ metabolomics, genomics, and functional
analyses to interrogate the in vivo 2-AA effects on mitochondrial
function. We use Nuclear Magnetic Resonance (NMR) spectros-
copy, which can demonstrate mitochondrial dysfunction [35],[36]
to assess physiological and metabolic biomarkers in intact muscle;
and in vivo NMR, to assess functional mitochondrial metabolism.
This technique is superior to biopsy-based genomic analysis, which
can only interrogate mitochondrial capacity versus function [37].
Our results show that 2-AA, beyond its previously identified
immunomodulatory activity [31], triggers host metabolic changes
that occur concurrently with mitochondrial and skeletal muscle
dysfunction, to promote pathogenicity.
Materials and Methods
Experimental animals
6-wk-old male CD1 mice weighing approximately 20–25 g were
purchased from Charles River Laboratory (Boston, MA). The
animals were maintained on a regular light-dark cycle (lights on
from 8:00 h to 20:00 h) at an ambient temperature of 2261uC,
with free access to food and water. Mice were injected intra-
peritoneally (IP) with 100 ml of 2-AA (6.75 mg /kg mice), and
mouse skeletal muscle was analyzed 4 days post 2-AA treatment.
In vivo
31P NMR spectroscopy was performed on intact mice, and
ex- vivo
1H NMR spectroscopy was performed on intact
gastrocnemious muscle samples.
Ethics Statement
This study was carried out in strict accordance with the
recommendations of the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Committee on the Ethics of Animal
Experiments at Massachusetts General Hospital (Permit Number:
2006N000093/2). All procedures were performed under sodium
pentobarbital anesthesia, and every effort was made to minimize
suffering.
31P NMR spectroscopy
Data acquisition. The theoretical basis of saturation transfer
experiments and calculations were as described by Forsen and
Hoffman [36], [38]. Animals were analyzed using in vivo
31P NMR
spectroscopy 4 days post 2-AA treatment. Mice were transiently
anesthetized with isoflurane (3.0%) plus O2 (2.0 l/min) delivered
through a nose cone, and then placed in a customized restraining
tube. Each animal’s right hind limb was placed into a solenoid coil
(four turns; length, 2 cm; diameter, 1 cm) tuned to
31P frequency
(162.1 MHz). During MR imaging, mice were continuously
anesthetized with isoflurane (1.5%) plus O2 (1.0 l/min). The
rectal body temperature was maintained at 3761uC using heated
water blankets. All in vivo
31P NMR experiments were performed
in a horizontal bore magnet (proton frequency at 400 MHz,
21 cm diameter, Magnex Scientific, Varian, Palo Alto, CA, USA)
using a Bruker Advance console. Field homogeneity was adjusted
using the
1H signal of tissue water. A 90u pulse was optimized for
detection of phosphorus spectra (repetition time 2 s, 400 averages,
4,096 data points). Saturation 90u selective pulse trains (duration,
36.533 ms; bandwidth, 75 Hz) followed by crushing gradients
were used to saturate the c-ATP peak. The same saturation pulse
train was also applied downfield of the inorganic phosphate (Pi)
resonance, symmetrically to the c-ATP resonance. T1 relaxation
times of Pi and phosphocreatine (PCr) were measured using an
inversion recovery pulse sequence in the presence of c-ATP
saturation. An adiabatic pulse (400 scans; sweep width, 10 kHz;
4,000 data points) was used to invert Pi and PCr, with an inversion
time between 152 and 7,651 ms.
Data analysis.
31P NMR spectra were analyzed using the
MestReNova NMR software package (Mestrelab Research S.L., v.
6.2.1 NMR solutions, Website: www.mestrec.com). Free induction
decays were zero-filled to 8,192 points and apodized with
exponential multiplication (30 Hz) before Fourier transformation.
The spectra were then manually phased and corrected for baseline
broad features using the Whittaker smoother algorithm [39]. The
Levenberg–Marquardt algorithm was used to least-square-fit a
model of mixed Gaussian/Lorentzian functions to the data.
Similarly, the T1obs relaxation time for Pi and PCr was calculated
by fitting the function y = A1 (1– A2e
2(t/T1obs)) to the inversion
recovery data, where y is the z magnetization, and t is the inversion
time.
Calculation of intramyocellular pH. The formula pH
=6.75+ log[(s–3.27)/(5.69–s)], where s is the chemical shift
difference (in ppm) between the Pi and the PCr peaks [40] was
used to calculate intramyocallular pH.
Calculation of ATP concentration. ATP concentration was
measured using the Bioluminescence Assay Kit CLS II, Cat#
1699695 (Roche Diagnostics Corporation, Indianapolis, IN
46250–0414, USA).
Calculation of ATP synthesis rate.
31P-NMR spectra data,
and the ATP concentration, were used to calculate the ATP
synthesis rate, as described by Forsen and Hoffman [38]. In brief,
the chemical reaction between Pi and ATP is:
Pi  ?
Kf
ATPandPi / 
Kr
ATP ð1Þ
Where kf and kr are reaction rate constants in each direction. The
influence of the chemical exchange between Pi and ATP on the
longitudinal magnetization M(Pi)of Pi is described by:
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dt
~
M0(Pi){M(Pi)
T1(Pi)
{kfM(Pi)zkrM(ATP) ð2Þ
At equilibrium
dM(Pi)
dt
~0

so at saturated ATP, M(ATP)~0

the equation (2) becomes
M(Pi)
M0(Pi)
~
1
1zkfT1(Pi)
: ð3Þ
The spin lattice relaxation time T1app, measured using the
inversion recovery pulse sequence in the presence of the ATP
saturation, is related to the intrinsic T1(Pi) by:
1
T1app
~
1
T1(Pi)
zkf ð4Þ
Combining (3) and (4) gives:
kf~
1
T1app
|
DM(Pi)
M0(Pi)
ð5Þ
where
DM(Pi)
M0(Pi)
is the fractional change of the longitudinal
magnetization M(Pi) of Pi. All the quantities on the right side of
(5) can be calculated from the NMR data. Finally the unidirec-
tional ATP synthesis flux can be calculated as
dATP
dt

synth
~kf Pi ½  ð 6Þ
where Pi is the concentration of Pi extrapolated from the baseline
NMR spectrum by comparing the peak integrals from Pi and c-
ATP, with respect to ATP concentration.
Extraction of RNA Samples
The left gastrocnemius muscle was harvested at 4 days post 2-
AA treatment (n=3, for each time point), to determine changes in
whole muscle gene expression. Mice were anesthetized by IP
injection of 40 mg/kg pentobarbital, and the muscle specimens
were excised and immediately immersed in 1 ml Trizol
(GibcoBRL, Invitrogen, Carlsbad, CA) for RNA extraction. All
mice were then administered a lethal dose of pentobarbital
(200 mg/kg) by IP injection. Each muscle specimen was homog-
enized for 60 s with a Brinkman Polytron 3000 before total RNA
extraction. Chloroform (200 ml) was added to the homogenized
muscle and mixed by inverting the tube for 15 s. After
centrifugation at 120006g for 15 min, the upper aqueous phase
was collected and precipitated by adding 500 ml isopropanol.
Further centrifugation at 120006g for 10 min separated the RNA
pellet, which was then washed with 500 ml of 70% ethanol and
centrifuged at 75006g for 5 min prior to air drying. The pellet was
resuspended in 100 ml DEPC-H20. An RNeasy Kit (Qiagen,
Maryland, USA) was used to purify the RNA according to the
manufacturer’s protocol. Purified RNA was quantified by UV
absorbance at 260 nm and 280 nm, and stored at 270uC for
DNA microarray analysis.
High-Resolution Magic Angle Spinning (HRMAS)
1H NMR
spectroscopy of intact skeletal muscle tissue
At 4 days post 2-AA treatment, three experimental and three
untreated control animals were analyzed with HRMAS
1H NMR.
The skeletal muscle tissue underlying the hind limb burn site was
harvested, immediately frozen in liquid nitrogen, and stored at
280uC. HRMAS
1H NMR spectroscopy of muscle tissue was
performed on a Bruker Bio-Spin Avance NMR spectrometer
(proton frequency at 600.13 MHz, 89 mm Vertical Bore) using a
4-mm triple resonance (
1H,
13C,
2H) HRMAS probe (Bruker,
Billerica, Massachusetts). The temperature was maintained at 4uC
with a BTO-2000 thermocouple unit in combination with a magic
angle spinning (MAS) pneumatic unit (Bruker). The MAS speed
was stabilized at 4.060.001 kHz with a MAS speed controller.
1H
NMR spectra were acquired using a Carr-Purcell-Meiboom-Gill
(CPMG) spin echo pulse sequence, (90u-(t-180u-t)n-acquisition),
with an inter-pulse delay (t) of 250 ms. Hard 90u (8 ms) and 180u
(16 ms) pulse trains were employed. The relaxation delay was set to
2 s, and spectra were collected both with and without water
suppression. The transverse relaxation time (T2) was measured
using the same CPMG pulse sequence by varying n from 0 to 520.
Free induction decay (FID) signals were acquired with 8 k points,
600 ms acquisition time, 8 dummy scans, and 128 scans.
HRMAS
1H NMR spectra were analyzed using the MestRe-C
NMR software package (Mestrelab Research, Santiago de
Compostela, Spain, www.mestrec.com). FIDs were zero-filled to
16 k points, and apodized with exponential multiplication (1 Hz)
before Fourier transformation. The spectra were then manually
phased and corrected for baseline broadening (Whittaker smooth-
er, smooth factor 10,000). The Levenberg-Marquardt algorithm
was used to least-squares-fit a model of mixed Gaussian/
Lorentzian functions to the data.
The (CH2)n22 peak at 1.32 ppm was selected for quantification
of intramyocellular lipids (IMCL). Because the sample was spun at
magic angle, and the sample volume was much smaller (25 ml) and
more homogeneous (reduced bulk magnetic susceptibility effects)
than the typical voxel size (1 ml) of in vivo
1H MRS, no chemical
shift difference was observed between IMCL and extramyocellular
lipids (EMCL). The small size of the muscle biopsies, and the fact
that the samples were collected from the most myocellular part of
the muscle, suggest that the main contribution to the (CH2) n22
peak was from IMCL lipids.
Absolute quantification of metabolites from 1-D CPMG
spectra
Resonance intensities were measured for -CH3 protons of
trimethylsilyl- propionic-2,2,3,3-d4 acid (TSP), and compared to
the resonance intensities measured for metabolite. The peak
intensities of most of the metabolites, as well as of TSP, were
calculated from the intensity of the respective resonance (X)
measured from the T2-filtered HRMAS
1H MR spectrum. The
calculated peak intensities were then corrected for T2 relaxation,
using Ic(X) = Ir(X) * exp(TCPMG/T2(X))/n, where Ir(X) is the
measured intensity, TCPMG is the CPMG echo time, and n is the
number of protons in the functional group, and corresponds to the
resonance of the metabolite. In accordance with the ‘‘external
standard’’ technique [41], metabolite concentrations were quan-
tified relative to the absolute concentration (mmol) of the respective
metabolite (M) = Ic(M)/(IcTSP(M) * wt), where wt is the weight of
the sample in grams.
Bacterial QS Affects Skeletal Muscle Function
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1H NMR spectroscopy data
Data are reported as means 6 standard errors of the mean.
Between-groups comparison was performed using analysis of
variance with Bonferroni correction for multiple comparisons.
Criterion for significance was p,0.0125 corrected. Comparison
between measurements was performed in each group with t-test
(two-tailed, p,0.0125). All analysis was performed using SPSS
(SPSS v12, SPSS Inc.).
Microarray hybridization
Biotinylated cRNA was generated with 10 mg of total cellular
RNA according to the protocol outlined by Affymetrix Inc. (Santa
Clara, CA, USA). The cRNA was hybridized onto MOE430A
oligonucleotide arrays (Affymetrix, CA, USA), stained, washed,
and scanned according to the Affymetrix protocol.
Genomic data analysis
Data files of the scanned image files hybridized with probes
from RNA extracted from the gastrocnemius muscle isolated at the
specified times from experimental and control mice (n=3) were
converted to cell intensity files (.CEL files) with the Microarray
suite 5.0 (MAS, Affymetrix, CA, USA). The data were scaled to a
target intensity of 500, and all possible pairwise array comparisons
of the replicates to normal control mice were performed for each
time point (i.e., four combinations when two arrays from each time
point were compared to the two arrays hybridized to RNA from
control mice) using a MAS 5.0 change call algorithm. Probe sets
that had a signal value difference greater than 100 and for which
one of the two samples being compared was not called ‘‘absent’’,
were scored as differentially modulated when 1) the number of
change calls in the same direction were at least 3, 4, and 6, when
the number of comparisons were 4, 6, and 9, respectively; and 2)
the other comparisons were unchanged. Based on the ratios of 100
genes determined to be invariant in most conditions tested
(Affymetrix, CA), an additional constraint of a minimum ratio of
1.65 was applied to control for the known false positives at 5%.
The Microarray data is available in http://www.ncbi.nlm.nih.
gov/geo/info/linking.html and the accession number is
GSE43779. GO analysis has been performed using the Gene-
Spring GX software (version 11) by Agilent Technologies.
Cell culture
The C2C12 murine skeletal muscle cell line (American type
culture collection, Bethesda, MD) was maintained in Dulbecco’s
modified Eagle’s medium (DMEM, Gibco) supplemented with
10% fetal bovine serum (Gibco) containing penicillin/streptomy-
cin and gentamycin (Gibco) in the presence of 5% CO2 at 37uC.
The cells were seeded in T-75 tissue culture flasks (Falcon, USA)
and used between passages 2 and 3.
2-AA cell treatment
C2C12 cells were plated at a density of 10
5/ml in 6-well plates
and grown overnight at 37uCi n5 %C O 2. Cells in the treatment
groups were treated with 0.8 mM 2-AA for 24, 36 and 48 h, and
then 2-AA treated or non-treated cells were washed with PBS.
Western blot analysis
Cellular extracts were prepared in RIPA buffer (Cell Signaling
Technology). Twenty five micrograms of total protein were added
to Laemmli buffer, boiled for 5 min, resolved by 7.5% or 10%
polyacrylamide gel electrophoresis (PAGE) in Tris/glycine/SDS
buffer (25 mM Tris, 250 mM glycine, 0.1% SDS), and transferred
to PVDF membranes (Bio-Rad, Hercules, CA). The membranes
were blocked for 2 h in TBS-T (20 mM Tris-HCL, 150 mM
NaCl, 0.1% Tween20) containing 5% non-fat milk. The
membranes were then washed three times in TBS-T and probed
overnight with rabbit antibodies specific for goat PPAR-c, rabbit
SIRT-1, mouse monoclonal PGC-1b (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA) at a dilution of 1:1,000, and mouse a-
tubulin (Santa Cruz Biotechnology, Inc) at a dilution of 1:2,000.
Figure 1. NMR spectra of in vivo
31P NMR saturation-transfer on
mouse hind limb skeletal muscle. Representative summed
31P-NMR
spectra acquired from control and 2-AA treated mice at day 4, before
(A) and after (B) saturation of the c-ATP resonance, with the difference
spectrum between the two shown below (A–B). The arrow on c-ATP
indicates the position of saturation (sat) by rf irradiation (22.4 ppm).
ppm, chemical shift in parts per million.
doi:10.1371/journal.pone.0074528.g001
Table 1. In vivo
31P-NMR saturation transfer analysis of limb
skeletal muscle from control and 2-AA treated mice.
Control (n=6) 2-AA(n=6) D (%) p-value
ATP synthesis flux (reaction PiRc-ATP)
DM/M0 0.3360.04 0.2360.02 230.6 0.015
T1obs (s) 1.1360.24 1.2660.19 11.5 NS
Kf (s
21) 0.2960.07 0.1860.03 237.9 0.005
ATP (mmol/g) 1.1960.28 0.2260.05 281.3 ,0.001
Pi (mmol/g) 0.3960.13 0.0660.02 284.2 0.011
ATP synthesis
rate (mmol/g/s)
0.11360.047 0.01160.004 290.3 0.008
ATP synthesis flux (reaction PCrRc-ATP)
DM/M0 0.3460.01 0.3160.02 28.1 (NS)
T1obs (s) 1.5960.20 1.6560.21 3.8 (NS)
Kf (s
21) 0.2160.03 0.1960.03 211.4 (NS)
ATP (mmol/g) 1.1960.28 0.2260.05 281.3 ,0.001
PCr (mmol/g) 4.1961.14 0.8560.24 279.7 ,0.001
ATP synthesis
rate (mmol/g/s)
0.88460.267 0.15960.049 282.0 ,0.001
Values are means 6 SEM; DM/M0 is the fractional change in Pi or PCr
magnetization as a result of saturation transfer; T1obs is the observed spin lattice
relaxation time of Pi or PCr during c-ATP saturation in seconds; Kf is the rate
constant for the reactions Pi R c-ATP and PCr R c-ATP, calculated as (1/T1obs)
6(DM/M0). ATP synthesis is calculated as Pi or PCr 6Kf. NS: not significant.
Unpaired one-tailed Student’s t-test was used for the comparisons.
doi:10.1371/journal.pone.0074528.t001
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with secondary horse-radish peroxidase (HRP)-conjugated rabbit
anti goat IgG, goat anti-rabbit IgG (Santa Cruz Biotechnology,
Inc) or goat anti-mouse IgG secondary antibodies (Promega,
Madison, WI), respectively for 1 h, and then washed three times in
TBS-T. The blots were visualized with SuperSignal West Pico
Figure 2. 2-AA treatment differentially modulates the genes involved in energy production and intermediate metabolism in
skeletal muscle. Differentially expressed genes involved in energy production (A) and intermediate metabolism (B) in response to 2-AA treatment.
Grey boxes represent up–egulation, and black boxes represent down-regulation, of the respective gene in muscle from 2-AA treated versus control
mice. The negative log10 of p-values represented by gray triangles are shown in the right vertical axis. The expression of certain key genes is down-
regulated, consistent with the in vivo
31P-NMR data (Figure 1 and Table 2).
doi:10.1371/journal.pone.0074528.g002
Table 2.
1H NMR HRMAS analysis on gastrocnemius muscle from 2-AA treated and control mice.
Chemical Shift PPM Chemical group Control 4 days Post 2-AA Percent Change p-value
1.30 (CH2)n 0.1460.01
a 0.0860.02 +118.9 0.029
b
Footnote:
a values (mmol/g muscle) are means 6 standard errors from 8 samples per group;
b p value for comparisons between 2-AA treated and control mice
obtained with the Student’s t-test; + indicates increase
doi:10.1371/journal.pone.0074528.t002
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according to the manufacturer’s instructions.
MTT assay for cell cytotoxicity
The cytotoxicity of cells treated with 0.8 mM 2-AA was
measured by MTT assay as previously described [31].
Plasma FFA assay
Blood was drawn by heart puncture at the time of sacrifice, and
the plasma FFA level was measured via the calorimetric FFA assay
kit that uses acylation of coenzyme A (NEFA C; Wako Chemicals
USA, Inc., Richmond, VA).
Neuromuscular Function Studies
Functional neuromuscular studies were performed to determine
the tensions developed after perturbation with the bacterial
molecule and test the integrity of neurotransmission at 4 days
post 2-AA treatment. Mice were anesthetized with pentobarbital
(60–70 mg/kg, IP), with adequate depth of anesthesia confirmed
by the absence of the withdrawal response to toe clamping.
Anesthesia was maintained with supplemental intermittent doses
of pentobarbital (10–20 mg/kg, IP), every 15–20 minutes. The
body temperature was monitored using a rectal thermistor and
maintained at 35.5–37uC with a heat lamp. Neuromuscular
transmission was monitored by evoked mechanomyography using
a peripheral nerve stimulator (NS252, Fisher & Paykel Health
Care, Irvine, CA) along with a Grass Force transducer and
corresponding software (Grass Instruments, Quincy, MA). With
the mice in dorsal recumbency, the tendon of insertion of the
tibialis muscle was surgically exposed on each side, and
individually attached to separate grass FT03 force displacement
transducers. The sciatic nerve was exposed at its exit from the
lumbosacral plexus at the thigh and tied with ligatures for indirect
nerve stimulation of the muscles. Distal to the ligatures,
stimulation electrodes were attached for nerve-mediated stimula-
tion of the tibialis muscle. The knee was rigidly stabilized with a
clamp to prevent limb movement during nerve stimulation.
Baseline tensions of 10 grams, which yielded optimal evoked
tensions, were applied on the immobilized and sham-immobilized
tibialis muscles. The sciatic-nerve-evoked tensions of the respective
tibialis muscles that were calibrated in grams of force were
recorded via a Grass P122 amplifier and displayed using the Grass
Polyview Software (Grass Instruments, Quincy, MA). Supramax-
imal electrical stimuli of 0.2 msec duration were applied to the
sciatic nerve at 2 Hz for 2 sec (train-of-four pattern, TOF), every
20 sec, using a Grass S88 stimulator and SIU5 stimulus isolation
unit (Grass Instruments, Quincy, MA). The evoked muscle tension
developed during TOF stimulation was recorded at the end of 15-
min. This was followed by tetanic stimulation at 50 Hz for 5 s to
assess the maximal tetanic muscle tension, and the muscle fade
associated with stimulus. All values are expressed as mean 6
S.E.M. (standard errors of mean). Differences between the two
sides of the 2-AA group and control mice were compared using
two-way ANOVA test and Bonferroni’s multiple comparison tests
as a Post hoc testing (GraphPad Prism version 5.00 for Windows,
GraphPad Software, San Diego California USA, www.graphpad.
com). Differences of p value ,0.05 were designated as significant.
Results
2-AA reduces ATP synthesis rate and energy production
gene expression in skeletal muscle without significantly
altering high-energy phosphates or pH
In vivo and ex vivo NMR magnetic spectroscopy allows
measurements of physiological and metabolic biomarkers in intact
systems [35], [36]. We used in vivo
31P NMR to assess the rate of
Figure 3. NMR spectra from
1H-NMR HRMAS analysis of gastrocnemius skeletal muscle from 2-AA treated versus control mice. The
spectra were acquired from 2-AA treated mice at 4 d versus control mice, and scaled to the phosphocreatine plus creatine peak (3.02 ppm).
Resonance signals of lipids correspond to: 1) terminal methyl CH3 protons (0.9 ppm); 2) acyl chain methylene protons (CH2)n of intramyocellular lipids
(IMCLs) (1.3 ppm); 3) methylene protons CH2C-CO (1.6 ppm); 4) allylic methylene protons C=C-CH2-C of monounsaturated fatty acyl moieties
(MUFAs) (2.05 ppm); 5) a methylene protons CH2CO (2.25 ppm); 6) diallylic methylene protons =C-CH2-C= of polyunsaturated fatty acyl moieties
(PUFAs); and 7) N-methyl protons of phosphocreatine and creatine (3.0 ppm), respectively. The NMR spectra demonstrate increased biomarkers of
insulin resistance IMCLs.
doi:10.1371/journal.pone.0074528.g003
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high-energy phosphates as a function of perturbed mitochondrial
function.
The levels of phosphomonoesters and inorganic phosphate and
the ratio Pi/PCr were decreased in the 2-AA treated mice versus
the control mice, whereas the levels of PCr were somewhat higher
in the 2-AA versus the controls, but not significantly. The
intramyocellular pH was not significantly different in the
experimental versus control animals (7.2660.06 and 7.3060.05,
respectively (p=0.60)).
31P NMR spectra were acquired from control and 2-AA treated
mice at day 4, before and after saturation of the c-ATP resonance.
Figure 1 shows the summed spectra (non-saturated (A)), upon
saturation of the c-ATP peak (B) with the difference spectrum (A-
B)) from the 6 control and the 6 2-AA-treated mice, with the mean
results presented in Table 1. The synthesis rates were derived from
the NMR data and the ATP concentration assays, with both
analyses demonstrating significantly decreased ATP levels in the 2-
AA versus the control mice. The fractional change, DM/M0, and
the observed spin lattice relaxation time, T1app, were used to
calculate the Kf rate constant using the equation
kf~
1
T1app
|
DM(Pi)
M0(Pi)
for the Pi R c-ATP reaction or
kf~
1
T1app
|
DM(PCr)
M0(PCr)
for the PCr R c-ATP reaction. The
ATP synthesis rate was obtained as the product of Kf and Pi
concentration. The NMR-measured fractional change for the Pi
R c-ATP reaction DM/M0 decreased by 30.6% in the 2-AA mice
versus the controls (percent change in DM/M0, Table 1). The ATP
concentration was lower in 2-AA mice versus controls by
approximately 81% (p,0.001 in the unidirectional (one-tailed) t-
test (Table 1). Likewise, the ATP synthesis rate was reduced by
90% in the 2-AA versus control mice (p,0.001unidirectional (one-
tailed) t-test). Accordingly, the unidirectional ATP synthesis rate
for the PCr R c-ATP reaction was significantly decreased by 82%
in the 2-AA versus control mice (one-tailed t-test, p,0.001).
Figure 2 presents the transcriptome results for the expression of
energy production (Fig. 2A) and intermediate metabolism (Fig. 2B)
genes, and demonstrates their expression was lower in the skeletal
muscle of the 2-AA versus control mice. Several components of the
mitochondrial respiratory (proton transport and/or electron
transport) chain were down-regulated, including subunits of
NADH dehydrogenases and ATP synthase (F1F0 ATPase or
complex V). Also genes involved in oxidative phosphorylation and
genes for acetyl-coA biosynthesis from pyruvate (Fig. 2B) were
significantly down-regulated. Moreover, the downstream TCA
cycle genes, including pyruvate dehydrogenase (lipoamide) beta,
succinate dehydrogenase subunits, and citrate synthase were
down-regulated. These results strongly suggest that 2-AA leads
to metabolic dysfunction in skeletal muscle.
2-AA increases insulin resistance biomarker IMCLs and
reprograms the expression of key metabolic genes
IMCL levels [42], [43] can serve as useful indices of insulin
resistance/metabolic abnormalities in non-vertebrates [44], and
vertebrates [45–47], including obese and/or type 2 diabetic
patients, where increased IMCL levels are due to impaired insulin-
stimulated glucose uptake [37], [48], [49]. Figure 3 shows
representative
1H-NMR spectra from control and 2-AA mice.
These results demonstrate a notable rise in IMCLs after 2-AA
treatment. Quantitative results of these data (Table 2) demonstrate
a significant rise in ICML 4 days post 2-AA treatment. Corre-
spondingly, the expression of genes involved in insulin signaling
(i.e., IRS1) and glucose transport (i.e., GLUT4) were down-
Table 3. Differential expression of key metabolic genes in skeletal muscle from 2-AA treated mice versus untreated control mice.
Gene Bank
Accession No. Name of Gene Gene Symbol GO Biological Process Fold Change p-value
BB345784 Insulin receptor substrate 1 Irs1 Insulin signaling 26.225 0.0382
NM_010514 insulin-like growth factor 2 Igf2 Insulin signaling 22.23 0.0309
BG092290 insulin-like growth factor 2 receptor lgf2r Insulin signaling 23.119 0.0106
NM_008344 insulin-like growth factor binding protein 6 lgfbp6 Insulin signaling 23.832 0.0137
BF225802 insulin-like growth factor binding protein 5 Igfbp5 Insulin signaling 23.208 0.0372
BB787243 insulin-like growth factor binding protein 4 Igfbp4 Insulin signaling 28.463 0.0076
AV257512 insulin induced gene 2 Insig2 Insulin signaling 22.768 0.0212
AB008453 solute carrier family 2 (facilitated glucose
transporter), member 4
Slc2a4 or GLUT4 Glucose transport 24.399 0.0438
NM_133249 peroxisome proliferative activated
receptor, gamma, coactivator 1 beta
Ppargc1b (PGC-
1b)
Lipid metabolism 22.904 0.00823
NM_011146 peroxisome proliferator activated
receptor gamma
Pparg (PPAR-c) Lipid metabolism 218.38 0.00256
AI645527 uncoupling protein 3 (mitochondrial,
proton carrier)
Ucp3 Mitochondrial uncoupling;
proton leackage
+5.291 0.00213
AW108044 uncoupling protein 2 (mitochondrial,
proton carrier)
Ucp2 Mitochondrial uncoupling;
proton leackage
22.3 0.00274
NM_019812 sirtuin 1 ((silent mating type information
regulation 2, homolog) 1 (S. cerevisiae)
Sirt1 muscle development 22.3 0.043
Values are the relative expression intensity of the 2-AA treated versus control mice after 4 d Gene annotations for biological functions are from the Gene Ontology
Consortium and the Ingenuity database.
(+) Upregulation of genes compared with control untreated muscle.
(2) Downregulation of genes compared with control untreated muscle.
doi:10.1371/journal.pone.0074528.t003
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expression in skeletal muscle post 2-AA treatment could lead to
metabolic dysfunction, including down-regulation of the PGC-1b,
PPAR-c lipid metabolism genes, the UCP2 mitochondrial
uncoupling: proton leackage gene, and Sirt1, which has been
proposed to lie at the center of a loop regulating the actions of
PGC and PPARs [50]; and up-regulation of the UCP3
mitochondrial uncoupling: proton leackage gene. Furthermore,
the protein expression level of PGC-1b, PPAR-c and Sirt1 was
significantly dampened in mouse skeletal muscle cell line C2C12
(Fig. 4) following 2-AA treatment, corroborating with our mouse
transcriptome data. This dampening effect was not due to 2-AA
cytotoxicity (Fig. 5).
Table 4 and Figure 2B show that 2-AA also alters fatty acid
oxidation. Several genes involved in lipid metabolism were down-
regulated (Fig. 2B). Eleven fatty acid oxidation genes were
differentially expressed post 2-AA treatment, with most being
down-regulated (Table 4). These genes encode proteins that
increase the non-esterified fatty acids cytosolic pool, and function
in fatty acid b-oxidation. Their reduced expression could
contribute to muscle lipid accumulation and the lipid metabolism
dysfunction produced by 2-AA. Plasma FFAs were not altered by
2-AA treatment.
In addition to this, the transcriptome data shows that stress
activated protein kinase (SAPK) pathway genes are significantly
downregulated (Table 5) in mouse skeletal muscle at 4 days 2-AA
treatment. Therefore, it confirms the specific action of 2-AA in
skeletal muscle.
2-AA affects skeletal muscle function
Since 2-AA reduces ATP synthesis rate and energy production
gene expression in skeletal muscle while reprograms the expression
of key metabolic genes as presented above, we carried out further
analysis and physiological studies to directly examine whether the
2-AA effects on metabolic gene expression and ATP synthesis
impact muscle function. Our results show that the expression of all
muscle contraction-related genes is significantly down regulated
(Table 6 and Fig. 6) as well as muscle development–related genes
(Fig. 6) indicating thus muscle dysfunction 4 days after 2AA
treatment. In addition, Table 7 shows that at 4 days post 2-AA
treatment, the absolute twitch tension of tibialis muscle was
significantly reduced in the 2-AA versus the control mice. The
evoked first single twitch tensions of tibialis muscle during TOF
stimulation in the 2-AA mice were reduced to 72% on the left side
and 80% on the right side, compared to the control mice (p,0.05).
The maximum response of tetanic stimulation (Tmax) also was
significantly different on the left side of 2-AA mice decreased 75%
versus the controls.
Discussion
We show here that 2-AA, a diagnostically important bacterial
interkingdom infochemical, leads to skeletal muscle dysfunction,
and induces a biological signature of mitochondrial dysregulation
and insulin resistance. Our results demonstrate that 2-AA down-
regulates genes, including PPAR-c, PGC-1b and Sirt1 that
function in mitochondrial biogenesis, oxidative phosphorylation,
and metabolic pathways, including insulin signaling, glucose
transport, energy production, fatty acid oxidation, and skeletal
muscle function. PPARs, in conjunction with PGC-1 and Sirt1,
activate oxidative metabolism genes, and mediate insulin sensitiv-
ity in skeletal muscle; and their dysregulation could underlie
metabolic dysfunction [50]. Such down-regulation may be
mediated via an upstream regulatory pathway involving mito-
chondrial uncoupling, and ultimately lead to the skeletal muscle
dysfunction observed here, and in burned skeletal muscle [35],
[36], [51]. To our knowledge, 2-AA is the first QS molecule seen
to promote these effects.
The 2-AA mediated suppression of PPAR-c correlates with the
reduced rate of ATP synthesis in the skeletal muscle of 2-AA
treated mice (Fig. 1 and Table 1), as well as the downregulation of
glucose transporter and insulin signaling genes (Table 3). The
transcription factor PPAR-c plays a pivotal role in maintaining
oxidative phosphorylation, insulin-mediated signaling, and glucose
homeostasis, along with other co-activators like PGC-1 and Sirt-1
Figure 4. 2-AA treatment dampens key metabolic protein
levels in mouse skeletal muscle cells. Western blotting of cellular
extracts with specific antibodies of PGC-1b, PPAR-c and Sirt-1 in 2-AA
treated cells at the indicated time points. One representative
experiment (out of three) is shown. Loading was normalized relative
to mouse a-tubulin. Densitometric data are the average of three
replicate experiments and are expressed as mean 6 SD (vertical
bars).*p,0.05 vs. naı ¨ve. DU, densitometric units.
doi:10.1371/journal.pone.0074528.g004
Figure 5. Effects of 2-AA on viability of mouse muscle cells. MTT
assay measuring cell viability in mouse skeletal muscle cells (C2C12)
after treatment with 0.8 mM 2-AA over time, as indicated in the figure.
SDs (vertical bars) were calculated from three replicate experiments.
doi:10.1371/journal.pone.0074528.g005
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suppression could affect energy homeostasis and insulin-induced
glucose metabolism in skeletal muscle, which could then cause
mitochondrial dysfunction and insulin resistance [55], [56].
Indeed, PPAR-c downregulation in CF deficient cells leads to
chronic inflammation [24], [57]. Also, PPAR-c overexpression can
rescue mitochondrial dysfunction in chronic mitochondrial disease
[58].
That 2-AA down-regulates PGC-1b and upregulates UCP3
(Table 3) is consistent with its reduction of ATP synthesis rate and
down-regulation of PPAR-c. The PGC-1b protein plays a major
role in mitochondrial metabolism, as it increases mitochondrial
biogenesis and muscle cell respiration [8]; and is hypothesized to
have a central role in regulating energy homeostasis and
metabolism [23], [35], [36]. As such, PGC-1b down-regulation
could lead to the down-regulation of oxidative phosphorylation
genes (OXPHOS) [35], [36], as their expression is down-regulated
by 2-AA (Fig. 2A). Consequently, these changes could lead to
mitochondrial uncoupling, as suggested by the up-regulation of
UCP3 (Table 3). To this end, our data suggest that 2-AA
dysregulates components of mitochondrial metabolism at the
transcriptional level, to result in skeletal muscle dysfunction
(Table 6–7). Interestingly, PPAR-c was suggested to act as the
N-acyl-homoserine lactone (AHL) signaling molecule N-3-oxodo-
decanoyl homoserine lactone (3-oxo-C12-HSL) mammalian re-
ceptor and it is shown to function as an antagonist of PPAR-c
transcriptional activity and inhibit the DNA binding ability of
PPAR-c [59].
Cells overexpressing PGC-1b exhibit increased activity of ATP
consuming reactions [8]. Here downreguation of PGC-1b
coincides with reduced ATP synthesis rate. That 2-AA also
reduces IRS1 expression (Table 3) suggests that PGC-1b, which is
downregulated here, perturbs IRS1 expression, and consequently
effects insulin resistance in skeletal muscle. As such, PGC-1 may
contribute to insulin resistance to then mediate inflammation and
disrupt glucose homeostasis [13]. In addition, the 2-AA mediated
down-regulation of Sirt1 (Table 3) is possibly associated with
energy expenditure and insulin sensitivity, and likely reflects the
Table 4. Differential expression of genes involved in fatty acid oxidation in mouse skeletal muscle at 4 days 2-AA treatment versus
control muscle.
Gene Bank Accession No. Gene Name Fold Change p- value
BG060909 stearoyl-Coenzyme A desaturase 2 +10.69 0.00507
NM_009127 stearoyl-Coenzyme A desaturase 1 24.379 0.0249
NM_010726 phytanoyl-CoA hydroxylase 24.708 0.000639
NM_010726 phytanoyl-CoA hydroxylase 24.708 0.000639
AK017272 lipoprotein lipase 28.606 0.00755
AK017272 lipoprotein lipase 28.606 0.00755
AK017272 lipoprotein lipase 28.606 0.00755
AK017272 lipoprotein lipase 28.606 0.00755
BB114220 L-3-hydroxyacyl-Coenzyme A dehydrogenase, short chain 26.56 0.002
AV018774 L-3-hydroxyacyl-Coenzyme A dehydrogenase, short chain 25.24 0.00184
NM_008212 L-3-hydroxyacyl-Coenzyme A dehydrogenase, short chain 25.945 0.0167
NM_010023 dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-Coenyme A isomerase) 25.248 0.00263
AK002555 acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) 24.842 0.0126
AK002555 acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) 27.626 0.00187
NM_133249 peroxisome proliferative activated receptor, gamma, coactivator 1 beta 22.904 0.00823
(+) Upregulation of genes compared with control untreated muscle.
(2) Downregulation of genes compared with control untreated muscle.
doi:10.1371/journal.pone.0074528.t004
Table 5. Downregulation of stress activated protein kinase (SAPK) pathway genes in mouse skeletal muscle at 4 days 2-AA
treatment versus control muscle.
Gene Bank Accession No. Gene Name Fold Change p-value
BM119623 activating transcription factor 2 22.160 0.0335
BG071068 guanine nucleotide binding protein (G protein), beta polypeptide 1 22.770 0.0165
AV021455 guanine nucleotide binding protein (G protein), gamma 2 24.480 0.0199
BQ175363 mitogen-activated protein kinase kinase kinase 9 28.400 0.00541
NM_009582 mitogen-activated protein kinase kinase kinase 12 22.012 0.0455
AF220195 mitogen-activated protein kinase 8 interacting protein 2 262.110 0.0116
AF262046 mitogen-activated protein kinase 8 interacting protein 3 23.759 0.0119
(2) Downregulation of genes compared with control untreated muscle.
doi:10.1371/journal.pone.0074528.t005
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tion factor PGC-1 functions in the regulation of differential gene
expression, in conjunction with other transcription factors (e.g.,
PPAR, SIRT-1), in cells exhibiting high energy-demands, includ-
ing skeletal muscle [8], [60], [61]. Here, 2-AA down-regulates
PGC-1b, IRS1, IGFs and GLUT4 expression (Table 3), indicating
a connection between PGC-1b and metabolic genes. This suggests
that PGC-1b acts to regulate energy metabolism genes in skeletal
muscle, and that mitochondrial dysfunction leads to the down-
regulation of the insulin signaling pathway, and impaired systemic
insulin activity (Fig. 7). To this end, our findings suggest a more
general role for PGC-1b in skeletal muscle metabolism, and
possibly in the progression of chronic infection [62], in addition to
the insulin resistance seen in obese and/or type 2 diabetic patients
[48], [49], [63], and CF patients with a high incidence of diabetes
[25].
2-AA also downregulates genes involved in fatty acid oxidation,
energy production, intermediary metabolism, and the TCA cycle
(Table 4; Fig. 2b) This downregulation could in turn lead to a
demand for increased muscle contractile gene expression to fulfill
functional requirements; however, our results show that 2-AA
reduces the expression of these genes (Fig. 6). This reduction could
underlie the observed muscle function impairment (Table 7), and
correspond to the impaired muscle strength in CF patients [64].
Our data suggest that this functional impairment may be due to
reduced mitochondrial coupling, as both ATP synthesis and TCA
flux are reduced, and the ratio of ATP synthesis and TCA flux can
serve as an index of mitochondrial coupling [37].
In vivo
31P magnetization-transfer can non-invasively determine
the unidirectional flux of Pi to ATP (‘‘ATP synthesis’’), and has
Figure 6. 2-AA treatment down-regulates muscle function.
Black bars indicate the number of down-regulated genes; gray bars
indicate the number of up-regulated genes, in the skeletal muscle of
mice 4 days post 2-AA treatment versus control mice (left vertical axis).
The negative log10 of p-values represented by gray triangles are
indicated on the right vertical axis.
doi:10.1371/journal.pone.0074528.g006
Table 6. Downregulation of muscle contraction genes in mouse skeletal muscle at 4 days 2-AA treatment versus control muscle.
Gene Bank Accession No. Gene Name Fold Change p-value
AK003186 tropomyosin 2, beta 22.822 0.0291
NM_010867 myomesin 1 26.41 0.0203
BM246564 phosphodiesterase 4B, cAMP specific 22.161 0.0488
AK002271 tropomyosin 1, alpha 23.175 0.021
BI248947 caldesmon 1 25.736 0.0334
BC003284 WD repeat domain 21 23 0.0288
BC024358 tropomyosin 2, beta 23.439 0.0359
AY094172 calcium channel, voltage-dependent, beta 1 subunit 22.317 0.0211
AA245637 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 22.121 0.0402
X53753 tropomyosin 3, gamma 22.399 0.0426
BC025840 titin 22.281 0.0397
AK013026 annexin A6 22.847 0.00242
AK010153 titin 23.873 0.0149
AW558570 endothelin receptor type A 24.527 0.0147
BB288010 myomesin 2 214.32 0.0221
BB705075 Calponin 3, acidic (Cnn3), mRNA 22.413 0.0044
BM122177 titin 22.901 0.0328
BB478751 titin 23.778 0.0137
NM_033268 actinin alpha 2 24.234 0.0349
BC026142 myosin, heavy polypeptide 11, smooth muscle 23.538 0.00149
NM_022314 tropomyosin 3, gamma 22.607 0.0251
BB474208 myomesin 2 28.349 0.039
BI663014 calponin 2 22.342 0.00402
BB833102 calponin 3, acidic 23.216 0.0354
AW108242 RIKEN cDNA 8030451F13 gene 22.775 0.0286
BM232388 tropomyosin 1, alpha 24.137 0.00079
AV241307 myomesin 2 210.55 0.0258
(2) Downregulation of genes compared with control untreated muscle.
doi:10.1371/journal.pone.0074528.t006
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obesity and diabetes [37]. This technique [65], [66] has enabled us
to noninvasively measure fast enzyme reaction exchange rates, to
provide an index of the net skeletal muscle rate of oxidative ATP
synthesis catalyzed by mitochondrial ATPase. This is by definition
proportional to the oxygen consumption rate by the P/O ratio,
e.g., the ratio of the net rate of ATP synthesis by oxidative
phosphorylation to the rate of oxygen consumption [67],[68].
Unidirectional ATP synthesis flux, measured by NMR, is thought
to primarily reflect flux through F1F0-ATP synthase, with
negligible influence of the coupled glyceraldehyde-3-phosphate
dehydrogenase (G3PDH), or phosphoglycerate kinase (PGK)
reactions [66]. Although the net glycolytic contribution of
G3PDH and PGK to ATP production is small, versus oxidative
phosphorylation, these enzymes occur at near equilibrium,
allowing high unidirectional ATP production. As such, we assume
the contribution of glycolytic reactions to unidirectional ATP
synthesis flux is negligible.
IMCLs levels are increased in mouse gastrocnemius muscle
following 2-AA treatment, as assessed by HRMAS
1H NMR
spectroscopy (Table 2 and Fig 3). Although the source of these
accumulated lipids is beyond this study, it has been shown that
EMCLs, IMCLs, and triglycerides all contribute to cellular lipid
peaks [42], [69], [70]. IMCL probably serve as energy substrates
for oxidative metabolism [71], and can be mobilized and utilized
with turnover rates of several hours [72]. Furthermore, the lipid
peak at 1.4 ppm in Figure 3 is attributed to methylene protons of
intra-myocellular triglyceride acyl chains, primarily due to IMCL
[42], to suggest that the increase in NMR-visible lipids at 1.4 ppm
post 2-AA treatment is primarily due to increased IMCL. This is
further supported by human studies [73],[74] where IMCLs were
suggested to serve as metabolic biomarkers of insulin resistance.
Nevertheless, lipid accumulation may reflect increased inflamma-
tion versus mitochondrial dysfunction [13], although 2-AA
immunomodulation is characterized by decreased inflammation
[31]. Here, increased IMCLs were associated with altered
expression of key regulators of insulin signaling and glucose
metabolism (Table 3), which can lead to insulin resistance in
association with mitochondrial dysfunction. To this end, 2-AA
might mediate insulin resistance, as IMCLs are biomarkers of such
resistance, and it down-regulates IRS1, IGFs, and GLUT4.
Nevertheless we have not directly demonstrated insulin resistance
by traditional methods.
Although the exact mechanism of abnormal insulin function is
unknown, there is increasing evidence that plasma FFAs may act
to induce insulin resistance [75]. However, intramyocellular
accumulation of toxic FFA metabolites, i.e. fatty acyl-coenzyme
A, diacylglycerol, and ceramides, has been also shown to impair
insulin signal transduction, glucose transport/phosphorylation,
and glycogen synthesis [46], [75], [76]. Because fatty acid
metabolism and glucose levels are closely linked, we propose that
the observed accumulation of lipids or triglycerides in muscle, may
lead to insulin resistance [77], although we did not observe any
alteration in plasma FFA, in agreement with the unchanged FFA
levels in CF patients [25]. In addition, previous studies have
suggested that muscle activity of lipoprotein lipase (LPL) is related
to insulin resistance [78] and that insulin may downregulate the
activity of lipoprotein lipase in skeletal muscle [79]. This is in
accordance with the decreased expression of the LPL gene in the
skeletal muscle of the 2-AA treated mice (Table 4).
CF patients often develop skeletal muscle wasting [80], and
insulin resistance [25], [81]. 2-AA mediated downregulation of
muscle gene functions is associated with tissue loss and low ATP
synthesis rate in skeletal muscle. Our results suggest that 2-AA may
act as an important contributor of host metabolic alterations in
disease states characterized by chronic infection. CF is one such
syndrome, where the associated pathophysiology stems as much
from the underlying gene mutation as from the colonization and
Table 7. Absolute wet-weights of tibialis (TA), soleus (So) and
gastrocnemius (GC) muscles, and absolute twitch tensions (ST;
single twitch, Tmax; maximum response of tetanic stimulation
at 50 Hz for 5 sec) of tibialis muscle, at 4 days post 2-AA
treatment, versus corresponding control muscle.
Wet weight
(mg) and twitch
height (g) Control 2-AA
Left Right Left Right
TA 54.063.2 54.762.4 45.763.5 47.362.2
So 8.160.8 8.060.5 7.860.3 8.460.8
GC 153.068.3 152.766.4 141.368.1 143.068.0
ST 44.661.3
1 45.061.7
" 32.263.4
1 35.861.9
"
Tmax 121.067.0
{ 118.765.0 90.967.0
{ 98.564.3
N 66
Values are means 6 SEM. Differences between the two sides of the 2-AA group
and control group were compared using one-way ANOVA test and Bonferroni’s
multiple comparison as a Post hoc testing. Differences were assumed to be
significant if the p-value was ,0.05. There are no significant differences in wet
muscle weights between the experimental and control mice (p.0.05). The
twitch heights of single twitch stimulation and tetanic stimulation show
significant differences between control and 2-AA mice (p,0.05).
1Significant difference of single twitch height between control and 2-AA group
in left side (p=0.043).
"Significant difference of single twitch height between control and 2-AA group
in right side (p=0.047).
{Significant difference of maximum response of titanic stimulation between
control and 2-AA group in left side (p=0.011).
Lt: Left side of muscle.
Rt: Right side of muscle.
doi:10.1371/journal.pone.0074528.t007
Figure 7. Schematic model for 2-AA mediated molecular
mechanisms of mitochondrial dysfunction in skeletal muscle.
2-AA triggers mitochondrial dysfunction via the down-regulation of
peroxisome proliferative activated receptor, gamma, coactivator (PGC)-
1b, peroxisome proliferator activated receptor (PPAR)-c, sirtuin (Sirt)-1,
the insulin signaling pathway, overall energy metabolism, and increased
lipid accumulation.
doi:10.1371/journal.pone.0074528.g007
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[82]. In acute infections, metabolic alterations are short-lived and
reverse quickly [83], [84], whereas in chronic infections the
protracted metabolic response leads to muscle wasting [85], [86].
P. aeruginosa and 2-AA in chronically infected CF lungs is
considered pathognomonic [32], [33], [87], [88]. As such, further
investigation into the potential clinical significance of 2-AA is
warranted, 2-AA modulates immune responses to promote host
tolerance and chronic infection [31]. To this end, it is possible that
the 2-AA mediated changes of the host metabolome may further
contribute to host tolerance and chronic P. aeruginosa infection.
Indeed, inhibition of PPAR-c reduces the phagocytic activity of
macrophages [89], which may serve to evade the host defense
mechanism, and possibly favor infection and allow long term
bacterial presence promoted by 2-AA [31]. Our results are
consistent with other chronic infections, including HIV [90],
tuberculosis [91], chronic Escherichia coli in skeletal muscle [92],
and chronically infected CF patients [93].
Conclusion
Based on our multidisciplinary results, Figure 7 proposes a novel
mode of action for the bacterial pathogen infochemical, 2-AA, to
mediate host metabolic dysregulation that results in mitochondrial
dysfunction, and potentially insulin resistance, in skeletal muscle.
The metabolic changes promoted by 2-AA may be clinically
relevant in molecular medicine in general, and CF in particular,
as: a) ATP synthesis rate and IMCLs can be measured clinically
using non-invasive and non-irradiating metabolomic assays; b)
PGC-1b activity may be induced; and c) PGC-1b agonists may
alleviate insulin resistance and prevent damage in organs remote
from the infection site. In addition, our results provide further
insights into the molecular and metabolic processes mediated by 2-
AA that accompany infections caused by 2-AA producing
pathogens, including Pseudomonas aeruginosa and Burkholderia species
[32], [33], as well as 2-AA-related molecules produced by other
pathogens.
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